MedTrace Logo

Covid-19 Vaccine Cohort in Specific Populations

NCT04824651 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 6920

Last updated 2022-02-04

No results posted yet for this study

Summary

Multicentre national cohort study with prospective data collection and biological specimen collection.

Ancillary study in this cohort : pediatric cohort with participants from 5 to 17 years old.

Enrollment complete for adult cohort. Active recruting for ancillary pediatric cohort.

Conditions

  • Immune Deficiency

Interventions

BIOLOGICAL

COVID-19 vaccine

Vaccination done as part of France's COVID-19 Vaccination Campaign

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Linda Wittkop, MDPhD · CHU de Bordeaux, Université de Bordeaux

  • Paul Loubet, MDPhD · CHU de Nimes, Université de Nimes

  • Odile Launay, MDPhD · Assistance Publique des Hôpitaux de Paris, Université de Paris

  • Romain Basmaci, MDPhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-25
Primary Completion
2024-06-25
Completion
2024-06-25

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04824651 on ClinicalTrials.gov